Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and Intchains Group (NASDAQ:ICG – Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.
Volatility and Risk
Firefly Neuroscience has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500. Comparatively, Intchains Group has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and target prices for Firefly Neuroscience and Intchains Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| Intchains Group | 1 | 1 | 2 | 0 | 2.25 |
Institutional & Insider Ownership
5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Firefly Neuroscience and Intchains Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
| Intchains Group | 36.01% | 8.98% | 8.56% |
Earnings & Valuation
This table compares Firefly Neuroscience and Intchains Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $110,000.00 | 127.54 | -$10.46 million | ($2.09) | -0.50 |
| Intchains Group | $38.60 million | 3.15 | $7.05 million | $0.21 | 9.52 |
Intchains Group has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Intchains Group, indicating that it is currently the more affordable of the two stocks.
Summary
Intchains Group beats Firefly Neuroscience on 10 of the 14 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About Intchains Group
Intchains Group Limited designs and sells application-specific integrated circuit chips for blockchain applications in the People's Republic of China. The company also offers ancillary software, hardware, and other products. It serves distributors. Intchains Group Limited was founded in 2017 and is based in Pudong, China.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
